HIV-1 envelope glycoproteins-mediated apoptosis is regulated by CD4 dependent and independent mechanisms

Apoptosis

Volumn 2, Issue 1, 1997, Pages 47-60

  Jacotot, E ^a   Krust, B ^a   Callebaut, C ^a   Laurent Crawford, A G ^a   Blanco, J ^a   Hovanessian, A G ^a,b  

^a CNRS   (France)

^b INSTITUT PASTEUR   (France)

Author keywords

Apoptosis; CD4; HIV; PMA

Indexed keywords

EID: 0002650112     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026435625144     Document Type: Article

References (87)

1. Littman DR. Preface. In: Littman DR, ed. 'The CD4 Molecule: Roles in T Lymphocytes and in HIV Disease'. Curr Top Microbiol Immunol 1996; 205.
2. Sakihama T, Smolyar A, Reinherz EL. Molecular recognition of antigen involves lattice formation between CD4, MHC class II and TCR molecules. Immunol Today 1995; 16: 581-587.
3. Dalgleish AG, Beverley PC, Clapham PR, Crawford DH, Greaves MF, Weiss RA The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 1984; 312: 763-767.
4. Klatzmann D, Champagne E, Chamaret S, et al. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 1984; 312: 767-768.
5. Ameisen JC, Estaquier J, Idziorek T. From AIDS to parasite infection: Pathogen mediated subversion of programmed cell death as a mechanism for immune dysregulation. Immunol Rev 1994; 142: 9-51
6. Banda NK, Bernier J, Kurahara DK, et al. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J Exp Med 1992; 176: 1099-1106.
7. Sheppard HW, Ascher MS. The relationship between AIDS and immunologic tolerance. J AIDS 1992; 5: 143-147.
8. Estaquier J, Idziorek T, De Bels F, et al. Programmed cell death and AIDS: Significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections. Proc Natl Acad Sci USA 1994; 91: 9431-9435.
9. Di Rienzo AM, Furlini G, Olivier R, Ferris S, Heeney J, Montagnier L. Different proliferative response of human and chimpanzee lymphocytes after contact with human immunodeficiency virus type 1 gp120. Eur J Immunol 1994; 24: 34-40.
10. Gougeon ML, Lecoeur H, Dulioust A, et al. Programmed cell death in peripheral lymphocytes from HIV-infected persons. J Immunol 1996; 156: 3509-3520.
11. + T cells by non-syncytium-inducing macrophage-tropic human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1994; 91: 10237-10241.
12. Wei X, Ghosh SK, Taylor ME, et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995; 373: 117-122.
13. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995; 373: 123-126.
14. Sodroski JG, Goh WC, Rosen A, Campbell K, Haseltine WA. Role of the HTLV/LAV envelope in syncytia formation and cytopathicity. Nature 1986; 322: 470-474.
15. Hovanessian AG. In Apoptosis II: The Molecular Basis of Apoptosis in Disease. Tomei DL, Cope FO, eds. Cold Spring Harbor, NY (USA): Cold Spring Harbor Laboratory Press, 1994: 21-42.
16. Terai C, Kornbluth RS, Pauza CD, Richman DD, Carson DA. Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1. J Clin Invest 1991; 87: 1710-1715.
17. Laurent-Crawford AG, Krust B, Muller S, et al. The cytopathic effect of HIV is associated with apoptosis. Virology 1991; 185: 829-839.
18. Cohen DI, Tani Y, Tian H, Boone E, Samelson LE, Lane HC Participation of tyrosine phosphorylation in the cytopathic effect of human immunodeficiency virus-1. Science 1992; 256: 542-545.
19. Laurent-Crawford AG, Krust B, Riviere Y, et al. Membrane expression of HIV envelope glycoproteins triggers apoptosis in CD4 cells. Aids Res Hum Retroviruses 1993; 9: 761-773.
20. Martin SJ, Matear PM, Vyakarnam A. HIV-1 infection of human CD4+ T cells in vitro,. Differential induction of apoptosis in these cells. J Immunol 1994; 152: 330-342.
21. Laurent-Crawford AG, Coccia E, Krust B, Hovanessian AG. Membrane-expressed HIV envelope glycoprotein heterodimer is a powerful inducer of cell death in uninfected CD4+ target cells. Res Virol 1995; 146: 5-17.
22. Connor RI, Mohri H, Cao Y, Ho DD. Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals. J Virol 1993; 67: 1772-1777.
23. Rey-Cuille MA, Galabru J, Laurent-Crawford A, Krust B, Montagnier L, Hovanessian AG. HIV-2 EHO isolate has a divergent envelope gene and induces single cell killing by apoptosis. Virology 1994; 202: 471-476.
24. Corbeil J, Richman DD. Productive infection and subsequent interaction of CD4-gp120 at the cellular membrane is required for HIV-induced apoptosis of CD4+ T cells. J Gen Virol 1995; 76: 681-690.
25. Maldarelli F, Sato H, Berthold E, Orenstein J, Martin MA. Rapid induction of apoptosis by cell-to-cell transmission of human immunodeficiency virus type 1. J Virol 1995; 69: 6457-6465.
26. Nardelli B, Gonzalez CJ, Schechter M, Valentine FT. CD4+ blood lymphocytes are rapidly killed in vitro, by contact with autologous human immunodeficiency virus-infected cells. Proc Natl Acad Sci USA 1995; 92: 7312-7316.
27. Kolesnitchenko V, Wahl LM, Tian H, et al. Human immunodeficiency virus 1 envelope-initiated G2-phase programmed cell death. Proc Natl Acad Sci USA 1995; 92: 11889-11893.
28. Tian H, Lempicki R, King L, Donoghue E, Samelson TE, Cohen DI. HIV envelope-directed signaling aberrancies and cell death of CD4+ T cells in the absence of TCR co-stimulation. Int Immunol 1996; 8: 65-74.
29. Dianzani U, Bragardo M, Buonfiglio D, et al. Modulation of CD4 lateral interaction with lymphocyte surface molecules inducedby HIV-1 gp120. Eur Immunol 1995; 25: 1306-1311.
30. + T cells. Virology 1996; 223: 318-330.
31. Bedinger P, Moriarty A, Von Borstel II RC, Donovan NJ, Steimer KS, Littman DR. Internalization of the human immunodeficiency virus does not require the cytoplasmic domain of CD4. Nature 1988; 334: 162-165.
32. Laurent-Crawford AG, Hovanessian AG. The cytopathic effect of human immunodeficiency virus is independent of high levels of unintegrated viral DNA accumulated in response to superinfection of cells. J Gen Virol 1993b; 74: 2619-2628.
33. Sato H, Orenstein J, Dimitrov D, Martin M. Cell-to-cell spread of HIV-1 occurs within minutes and may not involve the participation of virus particles. Virology 1992; 186: 712-724.
34. Busso M, Thornythwaite J, Resnick L. HIV-induced syncytium formation requires the formation of conjugates between virus-infected and uninfected T-cells in vitro. AIDS 1991; 5: 1425-1432.
35. Waring P. DNA fragmentation induced in macrophages by gliotoxin does not require protein synthesis and is preceded by raised inositol triphosphate levels. J Biol Chem 1990; 265: 14476.
36. Arend MJ, Morris RG, Willye AH. Apoptosis, the role of endonuclease. American J Pathol 1990; 136: 593-602.
37. Schreiber SL, Crabtree GR. The mechanism of action of cyclosporin A and FK506. Immunol Today 1992; 13: 136-142.
38. Shi Y, Sahai BM, Green DR. Cyclosporin A inhibits activation-induced cell death in T-cell hybridomas and thymocytes. Nature 1989; 339: 625-626.
39. Martin SJ, Lennon SV, Bonham AM, Cotter TG. Induction of apoptosis (programmed cell death) in human leukemic HL-60 cells by inhibition of RNA or protein synthesis. J Immunol 1990; 145: 1859.
40. Jacotot E, Callebaut C, Blanco J, et al. Dipeptidyl-peptidase IV beta, a novel form of cell-surface-expressed protein with dipeptidyl-peptidase IV activity. Eur J Biochem 1996; 239: 248-258.
41. Corbeil J, Tremblay M, Richman DD. HIV-induced apoptosis requires the CD4 receptor cytoplasmic tail and is accelerated by interaction of CD4 with p561ck. J Exp Med 1996; 183: 39-48.
42. Jowett JB, Planelles V, Poon B, Shah NP, Chen ML, Chen IS. The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle. J Virol 1995; 69: 6304-6313.
43. He J, Landau NR. Use of a novel human immunodeficiency virus type 1 reporter virus expressing human placental alkaline phosphatase to detect an alternative viral receptor. J Virol 1995; 69: 4587-4592.
44. Westendorp MO, Frank R, Ochsenbauer C, et al. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 1995; 375: 497-500.
45. Arunagiri C, Macreadie I, Azad A HIV-1 vpr penetrates human cells, localises in the nucleus and causes death by apoptcsis. In: Retrodnises. Cold Spring Harbor, NY (USA): Cold Spring Harbor Laboratory Press, 1996.
46. Stewart SA, Jowett JBM, Poon B, Chen ISY. HIV-1 vpr Causes Cell Cycle Arrest and Apoptosis. In: Retroviruses. Cold Spring Harbor, NY (USA): Cold Spring Harbor Laboratory Press, 1996.
47. Zauli G, Gibellini D, Celeghini C, et al. Pleiotropic effects of immobilized versus soluble recombinant HIV-1 Tat protein on CD3-mediated activation, induction of apoptosis, and HIV-1 long terminal repeat transactivation in purified CD4+ T lymphocytes. J Immunol 1996; 157: 2216-2224.
48. Naruyama NI, Brenner S. A phorbol ester/diacylglycerol-binding protein encoded by the unc-13 gene of C. elegans. Proc Natl Acad Sci USA 1991; 88: 5729.
49. Amhed S, Lee J, Kozma R, Best A, Monfries A, Lim A. A novel functional target for tumor promoting phorbol esters and lysophospatidic acid. J Biol Chem 1993; 268: 10709.
50. Gulbins E, Goggeshall KM, Langlet C, et al. Activation of Ras in vitro, and in intact fibroblasts by the Vav guanine nucleotide exchange protein. Mol Cell Biol 1994a; 14: 906-13.
51. MacConkey DJ, Orrenius S, Jondal M Cellular signaling in programmed cell death (apoptosis). Immunol Today 1990; 11: 120-121.
52. Chowdhury IH, Koyanagi Y, Kobayashi S, et al. The phorbol ester TPA strongly inhibits HIV-1-induced syncytia formation but enhances virus production: possible involvement of protein kinase C pathway. Virology 1990; 176: 126-132.
53. Golding H, Manischewitz J, Vujcic L, Blumenthal R, Dimitrov DS. The phorbol ester phorbol myristate acetate inhibits human immunodeficiency virus type 1 envelope-mediated fusion by modulating an accessory component(s) in CD4-expressing cells. J Virol 1994; 68: 1962-1969.
54. Marsh M, Pelchen-Matthews A. Endocytic and exocytic regulation of CD4 expression and function. In: Littman DR, ed. The CD4 Molecule: Roles in T Lymphocytes and in HIV Disease'. Curr Top Microbiol Immunol 1996; 205: 107-135.
55. Moore JP, Jameson BA, Weiss RA, Sattentau OJ. In: Bentz J, ed. Viral Fusion Mechanisms, 1993: 233-289.
56. Simmons G, McKnight A, Takeuchi Y, Hoshino H, Clapham PR. Cell-to-cell fusion, but not virus entry in macrophages by T-cell line tropic HIV-1 strains: a V3 loop-determined restriction. Virology 1995; 209: 696-700.
57. Callebaut C, Jacotot E, Krust B, Hovanessian AG. CD26 antigen and HIV fusion? Science 1994; 264: 1156-1165.
58. Mustelin T. Src Family Tyrosine Kinases in Leucocytes. Boca Raton, FL (USA): CRC Press, 1994: 74-75.
59. MacConkey DJ, Orrenius S. Signal transduction pathway to apoptosis. Trends Cell Biol 1994; 4: 370-374.
60. lck activation and TCR desensitrzation independent of TCR tyrosine phosphorylaticn. J Immunol 1994; 153: 2905-2917.
61. Turner JM, Brodsky MH, Irving BA, Levin SD, Perlmutter RM, Littman DR Interaction of the unique N-terminal region of tyrosine kinase p561ck with cytoplasmic dcmains of CD4 and CD8 is mediated by cysteine motifs. Cell 1990; 60: 755-765.
62. Malvoisin E, Wild F. Analysis of the human immunodeficiency virus type 1 envelope protein interaction with the CD4 host cell receptor. J Gen Virol 1994; 75: 839-847.
63. Fleischer B. CD26: a surface protease involved in T-cell activation. Immunol Today 1994; 15: 180-184.
64. Di Somma MM, Nuti S, Telford JL, Baldari CT. p56lck plays a key role in transducing apoptotic signals in T cells. Febs Latt 1995; 363: 101-104.
65. Torimoto Y, Dang NH, Vivier E, Tanaka T, Schlossman SF, Morimoto C Coassoriation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes. J Immunol 1991; 147: 2514-2517.
66. Mittler RS, Schieven GL, Dubois PM, A al. CD45-mediated regulation of extracellular calcium influx in a CD4-transfected human T cell line. J Immunol 1994; 153: 84-96.
67. Mustelin T. Src Family Tyrosine Kinases in Leucocytes. Boca Raton, FL (USA): CRC Press, 1994b: 53-68.
68. Irvine RF. Inositol phosphates and Ca2+ entry: toward a proliferation or a simplification? FASEB J 1992; 6: 3085-3091.
69. Hug H, Sarre TF. Protein kinase C isoenzymes: divergence in signal transduction? Biochem J 1993; 291: 329-343.
70. Munoz E. CD26 induces T-cell proliferation by tyrosine protein phosphorylation. Immunology 1992; 77: 43-50.
71. Tanaka T, Camerini D, Seed B, at al. Cloning and functional expression of the T cell activation antigen CD26 J Immunol 1992; 149: 481-486. [published erratum appears in J Immunol 1993; 150: 2090].
72. Hegen M, Camerini D, Fleischer B. Function of dipeptidyl peptidase IV (CD26, Tp103) in transfected human T cells. Cell Immunol 1993; 146: 249-260.
73. Arni S. Thy-1, CD26, CD45, p56lck, and p59fyn form multimeric complexes in the membrane of a T lymphoma. J Cell Biol 1994; 541(Suppl 18D):.
74. Jacotot E, Callebaut C, Hovanessian AG. On the induction of apoptosis by the HIV envelope glycoprotein complex. J Cell Biol 1994; 139(Suppl 18D):.
75. Gulbins E, Coggeshall KM, Baier G, Katzav S, Burn P, Altman A. Tyrosine kinase-stimulated guanine nucleotide exchange activity of Vav in T cell activation. Sceince 1993; 260: 822-825.
76. Gulbins E, Coggeshall KM, Baier G, et al. Direct stimulation of Vav guanine nucleotide exchange activity for Rasbyphorbol esters and diglycerides. Mol Cell Biol 1994b; 14: 4749-5478.
77. Feng Y, Broder CC, Kennedy PE, Berger EA HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996; 272: 872-877.
78. Golding H, Dimitrov DS, Manischewitz J, et al. Phorbol ester-induced down modulation of tailless CD4 receptors requires prior binding of gp120 and suggests a role for accessory molecules. J Virol 1995; 69: 6140-6148.
79. Lapham CK, Ouyang J, Chandrasekhar B, Nguyen NY, Dimitrov DS, Golding H. Evidence for cell-surface association between fusin and the CD4-gp120 complex in human cell lines. Science 1996; 274: 602-605.
80. Deng H, Liu R, Ellmeier W, Chos S, et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996; 381: 661-666.
81. Drajic T, Litwin V, Allaway GP, etal HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996; 381: 667-673.
82. Schnittman SM, Greenhouse JJ, Psallidopoulos MC, et al. Increasing viral burden in CD4+ T cells from patients with human immunodeficiency virus (HIV) infection reflect rapidly progressive immunosuppression and clinical disease. Ann Intern Med 1990; 113: 438-443.
83. Piatak M, Jr, Saag MS, Yang TC, et al. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 1993; 259: 1749-1754.
84. Gougeon MT, Laurent-Crawford AG, Hovanessian AG, Montagnier L Direct and indirect mechanisms mediating apoptosis during HIV infection: contribution to in vivo, CD4 T cell depletion. Sem Immunol 1993a; 5: 306-308.
85. Gougeon ML, Garcia S, Heeney J, et al. Programmed cell death in AIDS-related HIV and SIV infections. AIDS Res Hum Retroviruses 1993b; 9: 553-563.
86. Pantaleo G, Graziosi C, Demarest JF, et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993; 362: 355-358.
87. Finkel TH, Tudor-Williams G, Banda NK, et al. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nature Med 1995; 1: 129-134.